期刊文献+

根治性切除胰头癌患者临床病理资料与预后的关系 被引量:3

Relation Between Clinicopathologic Factors and Prognosis of Pancreatic Head Cancer Following Radical Resection
原文传递
导出
摘要 目的探讨根治性切除胰头癌患者的临床病理因素与预后的关系。方法回顾性分析兰州军区乌鲁木齐总医院2000年1月1日至2007年12月1日期间38例行根治性手术的原发性胰头癌患者的临床病理资料,采用SPSS 17.0软件进行统计学处理,分析临床病理特征间的相关性及其与预后的关系。结果 1本组38例胰头癌患者中有31例获得随访,随访率为81.6%,1年累积生存率为38.7%,2年累积生存率为12.9%。2 Spearman相关性分析各临床病理因素的关系发现,远处转移与肿瘤大小(rs=0.421,P=0.008)及TNM分期(rs=0.746,P=0.000)有关,淋巴结转移与TNM分期有关(rs=0.543,P=0.001),肿瘤大小也与TNM分期有关(rs=0.475,P=0.003)。3单因素分析影响胰头癌患者预后的临床病理因素结果表明,性别(P=0.045)、肿瘤大小(P=0.004)、分化程度(P=0.003)、TNM分期(P=0.000)、远处转移(P=0.002)及淋巴结转移(P=0.001)与胰头癌根治性手术后的预后有关,进一步多因素分析结果表明,TNM分期(P=0.001)、分化程度(P=0.003)及淋巴结转移(P=0.007)为胰头癌根治性手术后患者的预后影响因素。4 Kaplan-Meier法分析生存率的结果显示,中、高分化患者预后明显优于低分化患者(χ2=11.356,P=0.003);TNMⅠ+Ⅱ期患者的预后明显好于Ⅲ+Ⅳ期患者(χ2=15.970,P=0.000);无远处转移患者的预后明显好于有远处转移患者(χ2=9.248,P=0.002);无淋巴结转移患者的的预后明显好于有淋巴结转移患者(χ2=10.144,P=0.001)。结论淋巴结转移与TNM分期关系密切,而与分化程度无明显相关性;淋巴结转移、分化程度及TNM分期为胰头癌根治性手术后患者的预后影响因素。 Objective To investigate the correlation with clinicopathologic factors and prognosis in pancreatic head cancer following radical resection. Methods Thirteen-eight patients with primary pancreatic head cancer admitted into Urumuqi General Hospital of Lanzhou Military Region from January 2000 to December 2007 were treated by radical resection, the clinicopathologic factors were retrospectively analyzed, the SPSS 17. 0 analysis software was used to analyze the relation between clinicopathologic factors and prognosis. Results OThe follow-up rate was 81.6% (31/38), the 1- and 2-year overall survival was 38.7% and 12.9%, respectively. (~) Spearman analysis showed that the distant metastasis was significantly correlated with the tumor size (rs=0. 421, P=0. 008) and TNM stage (rs=0. 746, P=0. 000) ; the lymph node metastasis was significantly correlated with TNM stage (rs=0. 543, P=0. 001) and was not correlated with tumor differentiation degree (rs=0. 074, P=0. 695), the tumor size was also significantly correlated with TNM stage (rs=0. 475, P=0. 003). (3)Univariate Chi-Square test revealed that the gender (P=-0. 045), tumor size (P=0. 004), tumor differentiation degree (P=0. 003), TNM stage (P=-0. 000), distant metastasis (P=-0. 002), and lymph node metastasis (P=- 0. 001) were correlated with the prognosis of pancreatic head cancer. However, when the interactive effects of those factors were taken into account, TNM stage (P=0. 001), differentiation degree (P=-0. 003), and lymph node metastasis (P=-0. 007) were selected as the most significant prognostic factors in a multivariate analysis by using the Cox proportional hazard regression model. (4) The survival rate of patients with low differentiation degree was significantly shorter than that of moderate/high differentiation degree (P=-0. 003), of patients with Ⅰ +Ⅱ stages was significantly longer than that of Ⅲ +Ⅳ stages (P=0. 000), of patients with distant metastasis or lymph node metastasis was significantly lower than those patients without distant metastasis or lymph node metastasis (P=-0. 002, P=0. 001). Conclusions The lymph node metastasis is significantly associated with TNM stage, and is not associated with differentiation degree. The lymph node metastasis, differentiation degree, and TNM stage are related with survival, and they are also independent prognostic factors of pancreatic head cancer.
出处 《中国普外基础与临床杂志》 CAS 2014年第8期965-970,共6页 Chinese Journal of Bases and Clinics In General Surgery
基金 中国博士后科学基金第48批面上资助项目(编号:20100481517) 新疆维吾尔自治区自然科学基金资助项目(编号:2013211A073)~~
关键词 胰头癌 临床病理因素 预后 Pancreatic head cancer Clinicopathologic factor Prognosis
  • 引文网络
  • 相关文献

参考文献12

  • 1Hidalgo M. Pancreatic cancer [J]. N Engl J Med,2010,362 (17):1605-1617.
  • 2van der Gaag NA,Rauws EA,van Eijck CH,et al. Preoperative biliary drainage for cancer of the head of the pancreas [J]. N Engl J Med,2010,362(2):129-137.
  • 3Lau MK,Davila JA,Shaib YH. Incidence and survival of pan creatic head and body and tail cancers:a population-based study in the United States [J]. Pancreas,2010,39(4):458-462.
  • 4Sakai Y,Ishihara T,Tsuyuguchi T,et al. Clinical evaluation of endosonography-guided biliary drainage for patients with the difficulty with placing of internal drainage [J]. Hepatogastroenterology,2010,56(96):1596-1599.
  • 5左朝晖,欧阳永忠,周德善,莫胜川,谭春祁,江勃年,王心见.胰头癌的外科治疗[J].中华肿瘤杂志,2011,33(12):933-936. 被引量:6
  • 6钟守先.胰头癌根治术之我见[J].中国实用外科杂志,2004,24(5):262-263. 被引量:14
  • 7Massucco P,Ribero D,Sgotto E,et al. Prognostic significance of lymph node metastases in pancreatic head cancer treated with extended lymphadenectomy:not just a matter of numbers [J]. Ann Surg Oncol,2009,16(12):3323-3332.
  • 8Mckay A,Mackenzie S,Sutherland FR,et al. Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy [J]. Br J Surg,2006,93(8):929-936.
  • 9周江蛟,田艳涛,刘昊,张建伟,王成锋,赵平.胰腺癌临床病理特征与淋巴结转移的关系[J].中华肿瘤杂志,2013,35(2):132-134. 被引量:7
  • 10Di Giorgio A,Alfieri S,Rotondi F,et al. Pancreatoduodenectomy for tumors of Vater’s ampulla:report on 94 consecutive patients [J]. World J Surg,2005,29(4):513-518.

二级参考文献26

  • 1Riccardo Casadei,Claudio Ricci,Raffaele Pezzilli,Carla Serra,Lucia Calculli,Antonio Maria Morselli-Labate,Donatella Santini,Francesco Minni.A prospective study on radiofrequency ablation locally advanced pancreatic cancer[J].Hepatobiliary & Pancreatic Diseases International,2010,9(3):306-311. 被引量:7
  • 2倪泉兴,傅德良,蒋永剑,张群华,姚琪远,虞先浚,张延龄.胰头癌淋巴转移特点的探索和影响的因素[J].中华肝胆外科杂志,2004,10(4):231-234. 被引量:20
  • 3Illuminati G, Carboni F, Lorusso R, et al. Results of a pancreatec- tomy with limited venous reseetion for pancreatic cancer. Surg Today, 2008,38 : 517-523.
  • 4Di Giorgio A, Alfieri S, Rotondi F, et al. Pancreatoduodenectomy for tumors of Vater's ampulla: Report on 94 consecutive pa- tients. World J Surg,2005,29:513-518.
  • 5Fukuda S, Qussoultzoglou E, Bachellier P, et al. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma. Arch Surg, 2007,142 : 172-179.
  • 6Cooperman AM. Pancreatic cancer: the bigger picture. Surg Clin North Am, 2001,81:557-574.
  • 7Jemal A,Siegel R,Ward E. Cancer statistics,2007[J].CA:A Cancer Journal for Clinicians,2007.43-66.
  • 8Zacharias T,Jaeck D,Oussoultzoglou E. Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas[J].Journal of Gastrointestinal Surgery,2007.350-356.
  • 9Fujita T,Nakagohri T,Gotohda N. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas[J].Pancreas,2010.e48-e54.
  • 10Sierzega M,Popiela T,Kulig J. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer[J].Pancreas,2006.240-245.

共引文献50

同被引文献44

  • 1戴月娣,张德祥,袁苏徐,陶莉.胰腺癌治疗方式评价及预后分析[J].中国癌症杂志,2011,21(3):211-215. 被引量:11
  • 2郝志强,林杰,付庆才.CA19-9和CEA检测在胰头癌诊断的应用分析[J].实用肿瘤学杂志,2004,18(6):416-418. 被引量:5
  • 3洪国斌,周经兴,梁碧玲.影响中晚期胰腺癌预后因素的Cox回归分析[J].循证医学,2006,6(3):164-166. 被引量:6
  • 4Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer i"Clin, 2015, 65(1): 5-29.
  • 5Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer, 2007, 110(4): 738-744.
  • 6Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system, fourth edition. Lyon: LARC Press, 2010: 279-337.
  • 7Edge SB, Byrd DR, Compton CC, et al. AICC cancer staging manual. 7th ed. New York: Springer, 2010: 241-249.
  • 8Paiella S, De Pastena M, Esposito A, et al. Selective agenesis of pancreatic isthmus parenchyma with preservation of main pancreatic duct continuity, a very rare entity: case report. Int J Surg Case Rep, 2015, 6C: 169-171.
  • 9Xiao J, Peng F, Yu C, et al. MicroRNA-137 modulates pancreatic cancer cells tumor growth, invasion and sensitivity to chemotherapy. lnt J Clin Exp Pathol, 2014, 7(11): 7442-7450.
  • 10Chu D, Kohlmann W, Adler DG. Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromes. JOP, 2010, 11(3): 203-212.

引证文献3

二级引证文献4

相关机构

;
使用帮助 返回顶部